Showing results (1-10 of 1,636) with videos related to

Sort By:
Pageof 164
JAMA Cardiology|February 27, 2020
Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)Muthiah Vaduganathan, Brian L Claggett, Stephen P Juraschek, et al.
Journal of the American College of Cardiology|November 12, 2025
Timing of Mortality Benefit in Outcomes Trials in Transthyretin AmyloidosisBrian L Claggett, Marianna Fontana, Muthiah Vaduganathan, et al.
Journal of Cardiac Failure|February 3, 2022
Rates of Spironolactone Initiation and Subsequent Hyperkalemia Hospitalizations in Patients with Heart Failure with Preserved Ejection Fraction Following the TOPCAT trial: A Cohort Study of Medicare BeneficiariesRishi J Desai, Scott D Solomon, Muthiah Vaduganathan
JAMA Cardiology|September 15, 2021
Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the USMuthiah Vaduganathan, Brian L Claggett, Stephen J Greene, et al.
JACC. Heart Failure|June 15, 2020
Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the CommunitySenthil Selvaraj, Peder L Myhre, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|March 29, 2026
Effect of vutrisiran on components of health status in transthyretin amyloidosis with cardiomyopathy: the HELIOS-B studyYasuhiro Hamatani, Brian L Claggett, Muthiah Vaduganathan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2026
Systolic blood pressure and albuminuria reduction mediate cardiovascular benefits of finerenone in T2 diabetes and CKDRajiv Agarwal, Ambarish Pandey, Scott D Solomon, et al.
JACC. Heart Failure|January 1, 2021
Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19Ankeet S Bhatt, Karola S Jering, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|October 1, 2022
Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON-HF trialSafia Chatur, Brian L Claggett, Orly Vardeny, et al.
European Heart Journal|March 30, 2020
A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fractionMuthiah Vaduganathan, Pardeep S Jhund, Brian L Claggett, et al.
Pageof 164